APRE vs DHI · $10.4M cap vs P/E 9.6, rev $34.25B
Aprea Therapeutics Inc (APRE) versus DR Horton Inc (DHI) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
DR Horton Inc (DHI) is a residential construction company listed on US.
APRE does not have a complete income-statement cache yet.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
APRE currently screens at market cap $10.4M. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Not investment advice. Open the APRE and DHI stock pages for the full models.
Not investment advice.